Advertisement
Screener

BeyondSpring Inc. (BYSI) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

BeyondSpring Inc. Cash Flow Breakdown

Cash flow breakdown shows where BeyondSpring Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $19.77M went out.
  • Fiscal year ended 2025-12-31: from investing, $10.79M came in.
  • Fiscal year ended 2025-12-31: from financing, $4.97M came in.
  • Fiscal year ended 2025-12-31: change in cash, $3.91M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2025-12-31-$19.77M$10.79M$286.00K$2.00M$2.68M*-$3.91M
2024-12-31-$16.44M-$12.01M$3.91M$3.00M$19.87M*-$1.70M
2023-12-31-$16.47M-$100.00K$0.00$0.00-$16.65M
2022-12-31-$27.46M$17.56M$0.00$3.43M*-$7.23M
2021-12-31-$47.24M-$20.41M$0.00-$67.91M
2020-12-31-$43.74M-$52.00K$112.58M$5.26M*$73.60M
2019-12-31-$48.16M-$4.00K$69.45M$10.72M*$32.04M
2018-12-31-$39.95M$2.87M$14.00M-$755.00K*-$23.59M
2017-12-31-$28.80M-$3.15M$50.51M-$2.78M*$15.79M
2016-12-31-$13.70M-$64.00K$15.25M-$537.00K*$866.00K
2015-12-31-$6.57M$355.00K$1.00M$16.00M$10.43M
2014-12-31-$1.15M-$960.00K$2.50M*$384.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$3.77M*-$5.00K*-$74.00K*
2026-03-31-$3.28M$4.48M-$4.43M-$2.93M
2025-12-31-$5.50M*-$5.15M*$5.00K*$2.00M*
2025-09-30-$4.19M*-$1.22M*$0.00*$3.00M*
2025-06-30-$5.87M*$10.85M*$0.00*
2025-03-31-$4.20M$6.30M$0.00$2.11M
2024-12-31$982.00K*-$9.81M*-$157.00K*$0.00*$2.00M*
2024-09-30-$5.17M*-$2.20M*$0.00*$21.94M*
2024-06-30-$6.99M*$0.00*
2024-03-31-$5.27M$0.00-$5.32M
2021-12-31-$16.92M*-$4.73M*$0.00*
2021-09-30$2.83M*$9.34M*$0.00*
2021-06-30-$14.21M*-$25.01M*$82.00K*
2021-03-31-$18.94M-$8.00K-$82.00K-$18.96M
2020-12-31-$6.96M*-$18.00K*$80.64M*$5.25M*
2020-09-30-$11.46M*-$17.00K*$5.00M*-$508.00K*
2020-06-30-$14.27M*-$8.00K*$27.44M*
2020-03-31-$11.05M-$9.00K-$11.02M
2019-12-31-$12.68M*$0.00*$24.50M*-$541.00K*$11.26M*
2019-09-30-$22.38M*$0.00*$39.36M*$6.93M*$24.00M*
2019-06-30-$8.04M*$0.00*$0.00*$6.59M*-$1.29M*
2019-03-31-$5.06M-$4.00K$2.99M-$1.93M
2018-12-31-$8.32M*-$110.00K*$0.00*-$500.00K*-$8.95M*
2018-09-30-$9.60M*$2.99M*$0.00*-$6.57M*
2018-06-30-$13.10M*$0.00*$1.06M*
2018-03-31-$8.94M-$13.00K-$9.13M
2017-12-31-$10.18M*-$76.00K*$0.00*-$10.24M*
2017-09-30-$8.20M*-$3.05M*$0.00*-$11.26M*
2017-06-30-$5.13M*-$6.00K*$0.00*-$5.58M*
2017-03-31-$5.28M-$14.00K$50.51M-$2.33M*$42.88M
2016-12-31-$5.23M*$25.00K*$0.00*-$5.64M*
2016-09-30$11.70M*
2016-06-30-$3.03M*-$3.16M*
2016-03-31-$1.99M-$2.03M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30